
Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma
Jonathan W. Friedberg, Jennifer L. Kelly, Donna Neuberg, Derick R. Peterson, Jeffery L. Kutok, Rabih Salloum, Thomas Brenn, David C. Fisher, Elizabeth Ronan, Virginia Dalton, Lynn Rich, Diana Marquis,Volume:
146
Année:
2009
Langue:
english
Pages:
10
DOI:
10.1111/j.1365-2141.2009.07773.x
Fichier:
PDF, 339 KB
english, 2009